< Back to previous page
Researcher
Emmanuel Andre
- Disciplines:Biochemistry and metabolism, Microbiology, Systems biology, Laboratory medicine, Medical biochemistry and metabolism
Affiliations
- Laboratory of Clinical Microbiology (Division)
Member
From26 Jan 2018 → Today
Projects
1 - 5 of 5
- Impact of diagnostic delays and short treatment regimens on outcomes of rifampicin-resistant tuberculosis patients in CameroonFrom29 Jun 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Towards a Learning and Adaptive European pandemic Preparedness and emergency response SystemFrom1 Jan 2022 → TodayFunding: BOF - projects
- Leveraging indoor positioning systems for infectious disease controlFrom1 Jan 2021 → TodayFunding: IOF - technology validation in lab
- Point of care gathering and real-time utilization of smartphone generated movement traces of patients for infectious disease containment in the community.From6 Aug 2020 → TodayFunding: FWO Strategic Basic Research Grant
- Novel strategies against infectious diseasesFrom1 Nov 2005 → TodayFunding: IOF - Industrial Research Fund, IOF - mandates
Publications
1 - 10 of 39
- Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century(2022)
Authors: Lies Laenen, Emmanuel Andre
Number of pages: 8 - Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection.(2022)
Authors: Gijs Van Pottelbergh, Lode Godderis, Marc Van Ranst, Emmanuel Andre, Katrien Lagrou, Pieter Vermeersch
Pages: 115659 - Data-driven identification of communities with high levels of tuberculosis infection in the Democratic Republic of Congo.(2022)
Authors: Emmanuel Andre
Pages: 3912 - Comparison of the QuantiFERON-TB® Gold Plus on LIAISON® XL and T-SPOT.TB for the diagnosis of latent Mycobacterium tuberculosis infection in a low tuberculosis incidence population.(2022)
Authors: Emmanuel Andre
Pages: 115613 - Considerable escape of SARS-CoV-2 Omicron to antibody neutralization(2022)
Authors: Piet Maes, Simon Dellicour, Caspar Geenen, Bert Vanmechelen, Tony Wawina, Lize Cuypers, Emmanuel Andre
Pages: 671 - +Number of pages: 16 - Identification of the First SARS-CoV-2 Lineage B.1.1.529 Virus Detected in Europe(2022)
Authors: Bert Vanmechelen, Tony Wawina, Caspar Geenen, Lize Cuypers, Emmanuel Andre, Guy Baele, Piet Maes
Number of pages: 4 - Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern(2022)
Authors: Laura Vangeel, Steven De Jonghe, Piet Maes, Emmanuel Andre, Pieter Leyssen, Johan Neyts, Dirk Jochmans
Number of pages: 3 - Reliable and Scalable SARS-CoV-2 qPCR Testing at a High Sample Throughput: Lessons Learned from the Belgian Initiative(2022)
Authors: Marc Van Ranst, Lies Laenen, Emmanuel Andre
Number of pages: 14 - One year of laboratory-based COVID-19 surveillance system in Belgium: main indicators and performance of the laboratories (March 2020-21)(2021)
Authors: Emmanuel Andre, Lize Cuypers
Number of pages: 9 - Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients(2021)
Authors: Lize Cuypers, Emmanuel Andre
Number of pages: 12